Header cover image

Polish (WIG) Life Sciences Industry Analysis

UpdatedJul 23, 2024
DataAggregated Company Financials
Companies5
  • 7D-1.1%
  • 3M-1.8%
  • 1Y-11.9%
  • YTD0.1%

Over the last 7 days, the Life Sciences industry has dropped 1.1%, driven by Selvita declining 3.6%. Meanwhile, NanoGroup actually outperformed within the industry, gaining 72% in the last week. The industry has fallen 12% in the last year. In the next few years, earnings are forecast to decline by 1.0% annually.

Industry Valuation and Performance

Has the Polish Life Sciences Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Loading
Current Industry PE
  • Investors are relatively neutral on the Polish Life Sciences industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 6.4x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences industry have improved over the last three years.
  • Revenues for these companies have grown 23% per year.
  • This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.

Industry Trends

Which industries have driven the changes within the Polish Healthcare industry?

PL Market-2.67%
Healthcare0.79%
Life Sciences-1.09%
Clinical Research and Equipment-1.09%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NNG NanoGroupzł3.97102.6%
+zł39.3m
230.8%PB24.4x
MDB Medicofarma Biotechzł0.5616.9%
+zł5.5m
-61.9%PS28x
RVU Ryvu Therapeuticszł50.600.2%
+zł2.3m
-14.2%PS15.7x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

IGN

zł1.75

Inno-Gene

7D

-1.7%

1Y

n/a

RVU

zł50.60

Ryvu Therapeutics

7D

0.2%

1Y

-14.2%

NNG

zł3.97

NanoGroup

7D

102.6%

1Y

230.8%

MDB

zł0.56

Medicofarma Biotech

7D

16.9%

1Y

-61.9%